ANVISA Certification


Brazil’s Agencia Nacional de Vigilancia Sanitaria (ANVISA) approved Swiss BioQuant in Switzerland to conduct bioanalytical services as a center for bioavailability/bioequivalence studies. ANVISA certified that Swiss BioQuant meets the agency’s stringent biopharmaceutical safety guidelines allowing the company to conduct bioanalytical work on its clients drug products that will be marketed in Brazil. The certification will be valid until April 2019 and has been published on ANVISA website (ANVISA certificate Swiss BioQuant), National Health Surveillance Agency, www.anvisa.gov.br.

The Brazil regulatory agency will only accept or approve products for market that have had all bioavailability/bioequivalence assay work performed at certified facilities.